tiprankstipranks

BBP ETF Price & Analysis

Compare

BBP ETF Chart & Stats

ETF Overview

Virtus LifeSci Biotech Products ETF

The Virtus LifeSci Biotech Products ETF (Ticker: BBP) offers investors a targeted opportunity to delve into the dynamic and rapidly evolving biotechnology sector within the broader health care industry. Specializing in biotech companies, BBP is designed to capture the growth potential of firms at the cutting-edge of scientific innovation and medical advancements. This ETF focuses exclusively on firms involved in the development, production, and commercialization of biotechnology products, making it an ideal choice for investors seeking exposure to groundbreaking therapeutics and technologies that are reshaping the future of medicine. By investing in BBP, stakeholders gain access to a curated portfolio of pioneering biotech companies, offering a blend of established leaders and emerging innovators poised for substantial growth. Whether you are looking to tap into the transformative possibilities of biotechnology or aiming to diversify your investment portfolio with sector-specific exposure, the Virtus LifeSci Biotech Products ETF provides a strategic window into the forefront of health care innovation.

Virtus LifeSci Biotech Products ETF (BBP) Fund Flow Chart

Virtus LifeSci Biotech Products ETF (BBP) 1 year Net Flows: $3M

BBP ETF FAQ

What was BBP’s price range in the past 12 months?
BBP lowest ETF price was $50.43 and its highest was $69.12 in the past 12 months.
    What is the AUM of BBP?
    As of Feb 20, 2025 The AUM of BBP is 22.31M.
      Is BBP overvalued?
      According to Wall Street analysts BBP’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does BBP pay dividends?
        BBP pays a Notavailable dividend of $0.072 which represents an annual dividend yield of N/A. See more information on BBP dividends here
          How many shares outstanding does BBP have?
          BBP has 350,004 shares outstanding.
            Which hedge fund is a major shareholder of BBP?
            Currently, no hedge funds are holding shares in BBP

            BBP ETF Smart Score

            For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

            Top 10 Holdings

            Name
            Weight %
            Springworks Therapeutics
            2.42%
            Intra-Cellular Therapies
            2.41%
            Axsome Therapeutics Inc.
            2.14%
            Beigene, Ltd.
            2.12%
            Bridgebio Pharma
            2.08%
            Travere Therapeutics, Inc.
            2.06%
            SAGE Therapeutics, Inc. (US)
            1.97%
            Mirum Pharmaceuticals
            1.97%
            BioCryst Pharmaceuticals
            1.93%
            Gilead Sciences
            1.88%
            Total21.00%
            See All Holdings
            Popular ETFs
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis